Tapering, profit and equity prices
- As the US Federal Reserve’s tapering announcement is likely imminent, we offer an econometric quantification of the effect of the Fed’s quantitative easing (QE) programme on US equity prices, also taking into account interest rates, earnings and market stress
- Over the last two years, QE appears to explain nearly all the gains in equity prices in the S&P 500 index. However, we find that the information technology (IT) sector has been much more sensitive to QE than the rest of the index
- This does not necessarily mean that a correction is unavoidable when tapering starts. In our model, it is only when the Fed actively reduces its balance sheet by selling the securities it has acquired during QE that equity prices would be squeezed. We use our model to simulate what pace of Fed asset offloading would be consistent with stable equity prices
- Our model suggests that actual corporate earnings have no bearing on the equity valuation of IT stocks – contrary to what we find for the rest of the index. Only expected earnings seem to matter, and they have little connection with actual ones.
This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date.
All information in this document is established on data made public by official providers of economic and market statistics. AXA Investment Managers disclaims any and all liability relating to a decision based on or for reliance on this document. All exhibits included in this document, unless stated otherwise, are as of the publication date of this document.
Furthermore, due to the subjective nature of these opinions and analysis, these data, projections, forecasts, anticipations, hypothesis, etc. are not necessary used or followed by AXA IM’s portfolio management teams or its affiliates, who may act based on their own opinions. Any reproduction of this information, in whole or in part is, unless otherwise authorised by AXA IM, prohibited.
Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 22 Bishopsgate London EC2N 4BQ
In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.